# Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/linifanib-versus-sorafenib-in-patients-with-advanced-hepatocellular-carcinoma/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Călin Cainap,Shukui Qin,Wen‐Tsung Huang,Ik Joo Chung,Hongming Pan,Ying Cheng,Masatoshi Kudo,Yoon‐Koo Kang,Pei‐Jer Chen,Han-Chong Toh,Vera Gorbunova,Ferry A.L.M. Eskens,Jiang Qian,Mark D. McKee,Justin L. Ricker,Dawn M. Carlson,Saied El-Nowiem |
| Citations | 636 |
| DOI | 10.1200/jco.2013.54.3298 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2013.54.3298?role=tab |
| OpenAlex ID | https://openalex.org/W2120967735 |
| PMID | 25488963 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Pei‐Jer Chen](https://scholariq.org/researchers/pei-jer-chen/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Paper topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)
- [Silymarin and Mushroom Poisoning](https://scholariq.org/topics/silymarin-and-mushroom-poisoning/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.